NEO - NEOGENOMICS INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 14.14

Open

$ 13.74

Bid

$ 0.00 x 0

Ask

$ 14.14 x 100

Day's Range

$ 13.74 - $ 14.35

52 Week Range

$ 11.03 - $ 21.22

Volume

830,782

Average Volume

Market Cap

1.77B

Beta (5Y Monthly)

$ 1.40

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-20-2024	12-31-2023	10-K
2	11-06-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-24-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-09-2022	03-31-2022	10-Q
9	02-25-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	10-29-2020	09-30-2020	10-Q
15	07-31-2020	06-30-2020	10-Q
16	04-29-2020	03-31-2020	10-Q
17	02-28-2020	12-31-2019	10-K
18	11-13-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	02-26-2019	12-31-2018	10-K
22	11-06-2018	09-30-2018	10-Q
23	08-06-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	03-13-2018	12-31-2017	10-K
26	11-13-2017	09-30-2017	10-Q
27	08-07-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	03-14-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-05-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	03-15-2016	12-31-2015	10-K
34	11-06-2015	09-30-2015	10-Q
35	07-31-2015	06-30-2015	10-Q
36	05-11-2015	03-31-2015	10-Q
37	03-03-2015	12-31-2014	10-K
38	11-04-2014	09-30-2014	10-Q
39	07-29-2014	06-30-2014	10-Q
40	05-12-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

What 6 Analyst Ratings Have To Say About N...
03/18/2024 18:00:40

Earnings Scheduled For March 15, 2024
03/15/2024 09:15:18

Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on re...

Piper Sandler Maintains Overweight on NeoG...
02/26/2024 14:52:34

Piper Sandler analyst David Westenberg maintains NeoGenomics (NASDAQ:NEO) with a Overweight and raises the price target from...

Goldman Sachs Maintains Buy Rating for Neo...
02/22/2024 17:00:34

Why International Flavors & Fragrances Sha...
02/21/2024 18:50:15

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported m...

why-is-cancer-genetics-test-focused-neogenomics-stock-trading-higher-today

Why Is Cancer Genetics Test-Focused NeoGen...
02/21/2024 16:01:23

NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith ...

Toll Brothers Posts Upbeat Earnings, Joins...
02/21/2024 15:47:27

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

why-neogenomics-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Why NeoGenomics Shares Are Trading Higher ...
02/21/2024 13:06:42

Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-ex...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
02/21/2024 13:06:14

Evaluating NeoGenomics: Insights From 4 Fi...
02/21/2024 12:00:25

Needham Maintains Buy on NeoGenomics, Rais...
02/21/2024 10:32:50

Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $21 to $24.

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
02/20/2024 21:31:12

NeoGenomics Sees FY24 Adj. EPS $0.04 Vs $(...
02/20/2024 21:27:42

Recap: NeoGenomics Q4 Earnings
02/20/2024 21:10:20

NeoGenomics Q4 2023 Adj EPS $0.03 Beats $(...
02/20/2024 21:09:29

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.02) by...

Earnings Scheduled For February 20, 2024
02/20/2024 11:52:12

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

NeoGenomics's Earnings Outlook
02/19/2024 20:01:21

NeoGenomics Says It Signed For Working Wit...
02/01/2024 12:17:30

Expedia To Rally Around 10%? Here Are 10 T...
12/29/2023 14:20:13

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

TD Cowen Maintains Outperform on NeoGenomi...
12/29/2023 13:40:38

TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Outperform and lowers the price target from $22 to $19.